# A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma

> **NCT02749617** · PHASE2 · TERMINATED · sponsor: **University of British Columbia** · enrollment: 2 (actual)

## Conditions studied

- Anti-Xa Activity

## Interventions

- **DRUG:** apixaban

## Key facts

- **NCT ID:** NCT02749617
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08-09
- **Primary completion:** 2018-01-03
- **Final completion:** 2019-03-28
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study was stopped due to lack of enrollment.
- **Last updated:** 2021-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02749617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02749617, "A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02749617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*